[
  {
    "text": "<p>New funding applications are referred to one of Pharmac's Funding Application Advisors (FAAs), who'll review the application to ensure they have the relevant information to undertake a preliminary analysis.&nbsp; They may seek more information if required.</p>\r\n<p><a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/new-funding-applications/\" rel=\"nofollow\">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/new-funding-applications/</a></p>",
    "position": 0,
    "name": "Application Received",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Feb 2017",
          "fs": "Feb 2017",
          "change": null
        },
        "Event_Description": {
          "s": "Application received",
          "fs": "Application received",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P0000050jMOUAY"
          },
          "Id": "a0P2P0000050jMOUAY",
          "Event_Date__c": "2017-02-13",
          "Event_Description__c": "Application received",
          "Stage__c": "Application Received",
          "Formatted_Date__c": "Feb 2017",
          "Status_History__c": "a132P000000ArFtQAK"
        },
        "change": null
      }
    ],
    "dateString": "Feb 2017",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>Pharmac is identifying and gathering information required to get clinical advice.  The <a class=\"external-link\" href=\"https://pharmac.govt.nz/about/expert-advice/pharmacology-and-therapeutics-advisory-committee-ptac/\" rel=\"nofollow\">Pharmacology and Therapeutics Advisory Committee (PTAC)</a>  meets quarterly. There are also around 20 expert <a class=\"external-link\" href=\"https://pharmac.govt.nz/about/expert-advice/specialist-advisory-committees/\" rel=\"nofollow\">Specialist Advisory Committees (SACs)</a>, previously expert Subcommittees, which provide clinical evaluations in specialist areas. Specialist Advisory Committees meet as required to discuss issues referred to them by PTAC or Pharmac.</p>\n<p style=\"height: 20px\">&nbsp;</p>\n<p>In November 2021, we introduced separate terms of reference for the SACs to make clear that these committees have different, but complementary, roles, expertise and perspectives to PTAC.</p>\n<p style=\"height: 15px\">&nbsp;</p>\n<p>PTAC and SACs may make recommendations to Pharmac that differ from each other when looking at the same evidence. Pharmac considers the recommendations provided by all our clinical advisory committees when assessing applications.</p>\n<p style=\"height: 20px\">&nbsp;</p>\n<p><a class=\"external-link\" href=\"https://pharmac.govt.nz/about/expert-advice/pharmacology-and-therapeutics-advisory-committee-ptac/ptac-terms-of-reference-july-2021/\" rel=\"nofollow\">PTAC</a>  and <a class=\"external-link\" href=\"https://pharmac.govt.nz/about/expert-advice/specialist-advisory-committees/specialist-advisory-committee-terms-of-reference//\" rel=\"nofollow\">Specialist Advisory Committees</a> records of the meeting will be published on this website in accordance with the Terms of Reference.</p>",
    "position": 1,
    "name": "Seeking Clinical Advice",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": "During a NPPA review, the Subcommittee recommended that PHARMAC seek an application for tacrolimus ointment for the treatment of inflammatory dermatoses for community listing.",
          "fs": "During a NPPA review, the Subcommittee recommended that PHARMAC seek an application for tacrolimus ointment for the treatment of inflammatory dermatoses for community listing.",
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": "No Formal Recommendation",
          "fs": "No Formal Recommendation",
          "change": null
        },
        "Links": {
          "s": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-dermatology-subcommittee-minutes-2015-11.pdf\" target=\"_blank\">Dermatology Subcommittee minutes</a>",
          "fs": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-dermatology-subcommittee-minutes-2015-11.pdf\" target=\"_blank\">Dermatology Subcommittee minutes</a>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Nov 2015",
          "fs": "Nov 2015",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Dermatology Subcommittee at meeting Monday 30 November 2015.",
          "fs": "Clinical advice received from Dermatology Subcommittee at meeting Monday 30 November 2015.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P0000050jMNUAY"
          },
          "Id": "a0P2P0000050jMNUAY",
          "Event_Date__c": "2015-11-30",
          "Event_Description__c": "Clinical advice received from Dermatology Subcommittee at meeting Monday 30 November 2015.",
          "Stage__c": "Seeking Clinical Advice",
          "Links__c": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-dermatology-subcommittee-minutes-2015-11.pdf\" target=\"_blank\">Dermatology Subcommittee minutes</a>",
          "Outcome__c": "No Formal Recommendation",
          "Summary__c": "During a NPPA review, the Subcommittee recommended that PHARMAC seek an application for tacrolimus ointment for the treatment of inflammatory dermatoses for community listing.",
          "Formatted_Date__c": "Nov 2015",
          "Status_History__c": "a132P000000Ar2UQAS"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Mar 2017",
          "fs": "Mar 2017",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice required",
          "fs": "Clinical advice required",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P0000050jMPUAY"
          },
          "Id": "a0P2P0000050jMPUAY",
          "Event_Date__c": "2017-03-24",
          "Event_Description__c": "Clinical advice required",
          "Stage__c": "Seeking Clinical Advice",
          "Formatted_Date__c": "Mar 2017",
          "Status_History__c": "a132P000000ArGMQA0"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": "High",
          "fs": "High",
          "change": null
        },
        "Links": {
          "s": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-dermatology-subcommittee-minutes-2017-11.pdf\" target=\"_blank\">Dermatology Subcommittee minutes</a>",
          "fs": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-dermatology-subcommittee-minutes-2017-11.pdf\" target=\"_blank\">Dermatology Subcommittee minutes</a>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Oct 2017",
          "fs": "Oct 2017",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Dermatology Subcommittee at meeting Friday 20 October 2017.",
          "fs": "Clinical advice received from Dermatology Subcommittee at meeting Friday 20 October 2017.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P0000050jMQUAY"
          },
          "Id": "a0P2P0000050jMQUAY",
          "Event_Date__c": "2017-10-20",
          "Event_Description__c": "Clinical advice received from Dermatology Subcommittee at meeting Friday 20 October 2017.",
          "Stage__c": "Seeking Clinical Advice",
          "Links__c": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-dermatology-subcommittee-minutes-2017-11.pdf\" target=\"_blank\">Dermatology Subcommittee minutes</a>",
          "Outcome__c": "High",
          "Formatted_Date__c": "Oct 2017",
          "Status_History__c": "a132P000000ArLtQAK"
        },
        "change": null
      },
      {
        "Summary": {
          "s": "The Committee noted that the Dermatology Subcommittee recommended tacrolimus   ointment (0.03% and 0.1%) be listed for facial atopic dermatitis and subject to Special   Authority criteria. The Committee noted that this was given a high priority by the   Subcommittee. The Committee considered that there was a potential risk of high   volume use of this product due to patient numbers and amount applied topically, with   a subsequent high fiscal risk. For this reason, this application could be reviewed by   the Committee if further advice was requested by PHARMAC. The Committee   otherwise supported the recommendation and proposed Special Authority criteria.",
          "fs": "The Committee noted that the Dermatology Subcommittee recommended tacrolimus   ointment (0.03% and 0.1%) be listed for facial atopic dermatitis and subject to Special   Authority criteria. The Committee noted that this was given a high priority by the   Subcommittee. The Committee considered that there was a potential risk of high   volume use of this product due to patient numbers and amount applied topically, with   a subsequent high fiscal risk. For this reason, this application could be reviewed by   the Committee if further advice was requested by PHARMAC. The Committee   otherwise supported the recommendation and proposed Special Authority criteria.",
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": "No Formal Recommendation",
          "fs": "No Formal Recommendation",
          "change": null
        },
        "Links": {
          "s": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2018-02.pdf\" target=\"_blank\">PTAC minutes</a>",
          "fs": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2018-02.pdf\" target=\"_blank\">PTAC minutes</a>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Feb 2018",
          "fs": "Feb 2018",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 8 February 2018.",
          "fs": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 8 February 2018.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P0000050jNFUAY"
          },
          "Id": "a0P2P0000050jNFUAY",
          "Event_Date__c": "2018-02-08",
          "Event_Description__c": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Thursday 8 February 2018.",
          "Stage__c": "Seeking Clinical Advice",
          "Links__c": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-minutes-2018-02.pdf\" target=\"_blank\">PTAC minutes</a>",
          "Outcome__c": "No Formal Recommendation",
          "Summary__c": "The Committee noted that the Dermatology Subcommittee recommended tacrolimus   ointment (0.03% and 0.1%) be listed for facial atopic dermatitis and subject to Special   Authority criteria. The Committee noted that this was given a high priority by the   Subcommittee. The Committee considered that there was a potential risk of high   volume use of this product due to patient numbers and amount applied topically, with   a subsequent high fiscal risk. For this reason, this application could be reviewed by   the Committee if further advice was requested by PHARMAC. The Committee   otherwise supported the recommendation and proposed Special Authority criteria.",
          "Formatted_Date__c": "Feb 2018",
          "Status_History__c": "a132P000000ArPYQA0"
        },
        "change": null
      }
    ],
    "dateString": "Nov 2015",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>Following Clinical Advice, Pharmac staff considers the advice and the funding application under goes an assessment using our&nbsp;<a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/factors-for-consideration/\" rel=\"nofollow\">Factors for Consideration</a>&nbsp;framework and seeks additional information as required.</p>\r\n<p>&nbsp;</p>\r\n<p>Research and Economic analysis are undertaken.&nbsp; This focuses on the costs and benefits of a proposed course of action. Economics is based on three fundamental concepts that summarise the issues Pharmac faces daily:&nbsp;</p>\r\n<ul>\r\n<li>Scarcity &ndash; resources will always be insufficient to support all possible activities.</li>\r\n<li>Choices &ndash; due to scarce resources, decisions must be made about how best to use them.</li>\r\n<li>Opportunity cost &ndash; by choosing to use resources one way, we forgo other opportunities to use the same resources.</li>\r\n</ul>\r\n<p>&nbsp;</p>\r\n<p>For further information on the purpose of, and techniques for, undertaking economic analysis in health care, please refer&nbsp;<a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/economic-analysis/\" rel=\"nofollow\">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/economic-analysis/</a></p>",
    "position": 2,
    "name": "Under Assessment",
    "last": false,
    "events": null,
    "dateString": null,
    "collapsed": false,
    "checked": false
  },
  {
    "text": "<p>Pharmac staff uses a prioritisation process to compare and rank funding options. Possible opportunities for new investment will always exceed the budget Pharmac has available; therefore, prioritisation is an intrinsic part of Pharmac\u2019s decision-making process.</p>\r\n<p>The relative ranking of options aims to support Pharmac&rsquo;s statutory objective &ldquo;to secure for eligible people in need of pharmaceuticals, the best health outcomes that are reasonably achievable from pharmaceutical treatment and from within the amount of funding provided&rdquo;.</p>\r\n<p>A funding application or proposal is considered ready for prioritisation when sufficient information is available to permit it to be reviewed against Pharmac's Factors for Consideration and to inform a comparison with other possible investment decisions.</p>\r\n<p>There is no guarantee when or if a ranked medicine will be funded.&nbsp;&nbsp;<a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/prioritisation/\" rel=\"nofollow\">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/prioritisation/</a></p>",
    "position": 3,
    "name": "Options Compared",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Sep 2018",
          "fs": "Sep 2018",
          "change": null
        },
        "Event_Description": {
          "s": "The relative ranking of the pharmaceutical application has been completed.",
          "fs": "The relative ranking of the pharmaceutical application has been completed.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P0000050jNGUAY"
          },
          "Id": "a0P2P0000050jNGUAY",
          "Event_Date__c": "2018-09-04",
          "Event_Description__c": "The relative ranking of the pharmaceutical application has been completed.",
          "Stage__c": "Options Compared",
          "Formatted_Date__c": "Sep 2018",
          "Status_History__c": "a132P000000ArWfQAK"
        },
        "change": null
      }
    ],
    "dateString": "Sep 2018",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>Pharmac is consulting on a proposal to either approve or decline the application.&nbsp;We seek the views of all people who have an interest in our proposals, or who may be affected by them, to obtain feedback on our proposed approaches.</p>\r\n<p><a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/having-your-say/\" rel=\"nofollow\">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/having-your-say/</a></p>",
    "position": 4,
    "name": "Under Consultation",
    "last": false,
    "events": null,
    "dateString": null,
    "collapsed": false,
    "checked": false
  },
  {
    "text": "<p>Following the consultation process, Pharmac staff considers the feedback and identifies any additional information required as part of a gap analysis.&nbsp; The proposal may require further clinical advice, research, and assessment.</p>",
    "position": 5,
    "name": "Reviewing Consultation Feedback",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Feb 2021",
          "fs": "Feb 2021",
          "change": null
        },
        "Event_Description": {
          "s": "Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.",
          "fs": "Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P0000050jNHUAY"
          },
          "Id": "a0P2P0000050jNHUAY",
          "Event_Date__c": "2021-02-12",
          "Event_Description__c": "Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.",
          "Stage__c": "Reviewing Consultation Feedback",
          "Formatted_Date__c": "Feb 2021",
          "Status_History__c": "a132P000000CaanQAC"
        },
        "change": null
      }
    ],
    "dateString": "Feb 2021",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>We refer to our decisions about whether and how particular pharmaceuticals are publicly-funded, as &ldquo;funding decisions&rdquo;.</p>\r\n<p>We consider and assess all funding decisions using the&nbsp;<a class=\"external-link\" href=\"https://www.pharmac.govt.nz/about/operating-policies-and-procedures/#factorsfc\" rel=\"nofollow\">Factors for Consideration</a>. When we do so, we carefully evaluate clinical and other evidence for the benefits and suitability of a proposal, and to identify and understand the people who will be affected by it.</p>\r\n<p>While our main task is to allocate pharmaceutical funding, we consider the benefits and costs across the whole health system now and with a long-term focus, including the effects for hospitals and primary care, and consider direct costs to patients as well as to all health sector budgets.</p>\r\n<p>Final funding decisions are made by the Pharmac Board or delegated to senior Pharmac staff as required by the Board.</p>\r\n<p>&nbsp;</p>",
    "position": 6,
    "name": "Decision",
    "last": true,
    "events": [
      {
        "Summary": {
          "s": "<p><span style=\"font-size: 12px; color: rgb(51, 51, 51);\">The funding application has been approved and tacrolimus ointment will be funded for people with facial eczema, subject to funding restrictions from 1 October 2021. This decision resulted from PHARMAC\u2019s annual tender process.</span></p>",
          "fs": "<p><span style=\"font-size: 12px; color: rgb(51, 51, 51);\">The funding application has been approved and tacrolimus ointment will be funded for people with facial eczema, subject to funding restrictions from 1 October 2021. This decision resulted from PHARMAC\u2019s annual tender process.</span></p>",
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": "<p><a href=\"https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-2021-05-04-tacrolimus-ointment/\" target=\"_blank\">Notification letter</a></p>",
          "fs": "<p><a href=\"https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-2021-05-04-tacrolimus-ointment/\" target=\"_blank\">Notification letter</a></p>",
          "change": null
        },
        "Formatted_Date": {
          "s": "May 2021",
          "fs": "May 2021",
          "change": null
        },
        "Event_Description": {
          "s": "The funding application has been approved.",
          "fs": "The funding application has been approved.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0P2P0000050jNIUAY"
          },
          "Id": "a0P2P0000050jNIUAY",
          "Event_Date__c": "2021-05-04",
          "Event_Description__c": "The funding application has been approved.",
          "Stage__c": "Decision",
          "Links__c": "<p><a href=\"https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-2021-05-04-tacrolimus-ointment/\" target=\"_blank\">Notification letter</a></p>",
          "Summary__c": "<p><span style=\"font-size: 12px; color: rgb(51, 51, 51);\">The funding application has been approved and tacrolimus ointment will be funded for people with facial eczema, subject to funding restrictions from 1 October 2021. This decision resulted from PHARMAC\u2019s annual tender process.</span></p>",
          "Formatted_Date__c": "May 2021",
          "Status_History__c": "a132P000000CohgQAC"
        },
        "change": null
      }
    ],
    "dateString": "May 2021",
    "collapsed": false,
    "checked": true
  }
]